Drug
Emapalumab Lzsg
Emapalumab Lzsg: highest development phase Phase 2/3, developed by Swedish Orphan Biovitrum. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- Swedish Orphan Biovitrum
Trials
| Drug | Phase | Indication |
|---|---|---|
| Emapalumab-Lzsg NCT03985423 | Phase 2/3 | Hemophagocytic Lymphohistiocytoses |
Latest
No recent events.
Follow Emapalumab Lzsg on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.